Overview Adult Asthmatics and Acid Reflux Status: Completed Trial end date: 2004-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the efficacy and safety of Nexium in the treatment of subjects with persistent asthma believed to have acid reflux as a contributory factor to control of their asthma. Phase: Phase 2 Details Lead Sponsor: AstraZenecaTreatments: Esomeprazole